Metraipolis › archive › dc_f2c1e80d552f

Real-world neuropsychiatric safety profile of foslevodopa/foscarbidopa infusion in advanced Parkinson's disease — Europe PMC PMID:42766028

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42766028
DOI
10.1007/s00415-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-10-08T01:17:10.961Z
SHA-256 of the archived text
8d14221e009afbb449ec19fc7e6175671316570d41deed6d31fd77a6eaabe774
Stable URL of this page
https://metraipolis.com/documento/dc_f2c1e80d552f

How to cite

Real-world neuropsychiatric safety profile of foslevodopa/foscarbidopa infusion in advanced Parkinson's disease — Europe PMC PMID:42766028 — Europe PMC (en), https://europepmc.org/article/MED/42766028 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f2c1e80d552f (Metraipolis archive dc_f2c1e80d552f, sha256 8d14221e009afbb449ec19fc7e6175671316570d41deed6d31fd77a6eaabe774)
BibTeX
@misc{dcf2c1e80d552f,
  title = {Real-world neuropsychiatric safety profile of foslevodopa/foscarbidopa infusion in advanced Parkinson's disease — Europe PMC PMID:42766028},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42766028},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f2c1e80d552f; sha256 8d14221e009afbb449ec19fc7e6175671316570d41deed6d31fd77a6eaabe774},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42766028. Agents can read the archived copy with the MCP tool read_document.